Trial Profile
Phase 1 Study of Safety of Secretrol® in the Short-term Management of Patients Undergoing Endoscopic Mucosal Resection (EMR)
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 28 Feb 2017
Price :
$35
*
At a glance
- Drugs Lansoprazole/omeprazole (Primary)
- Indications Glandular and epithelial neoplasms; Oesophageal cancer
- Focus Adverse reactions
- Sponsors Effexus Pharmaceutical
- 08 Aug 2014 New trial record